![The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial]()
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trialTaylor, P. R. A.; White, J. M.; Prescott, R. J.; Angus, B.; Galloway, M. J.; Jackson, G. H.; Lessells, A. M.; Lucraft, H. H.; Summerfield, G. P.; Proctor, S. J.; On Behalf Of The Scotland and Newca, · Leukemia & Lymphoma · 2006